Dolutegravir/lamivudine/tenofovir
id:
dolutegravir-lamivudine-tenofovir-274-10062280
title:
Dolutegravir/lamivudine/tenofovir
text:
Dolutegravir/lamivudine/tenofovir (DTG/3TC/TDF) is a fixed-dose combination antiretroviral medication used to treat HIV/AIDS. It is a combination of dolutegravir, lamivudine, and tenofovir disoproxil. As of 2019, it is listed by the World Health Organization (WHO) as the first line treatment for adults, with tenofovir/lamivudine/efavirenz as an alternative. It is taken by mouth. Side effects may include trouble sleeping, weight gain, and rash. While there are concerns that use during pregnancy r
brand slug:
wiki
category slug:
encyclopedia
description:
Combination drug for HIV
original url:
https://en.wikipedia.org/wiki/Dolutegravir/lamivudine/tenofovir
date created:
date modified:
2023-10-02T04:24:25Z
main entity:
{"identifier":"Q85757327","url":"https://www.wikidata.org/entity/Q85757327"}
image:
fields total:
13
integrity:
14